Relationship between serum phosphorus levels and various outcome measures in adult hemodialysis patients.
OBJECTIVE
To compare three different mean serum phosphorus ranges on outcomes related to the control and treatment of hyperparathyroidism (HPTH), to nutritional status, and to quality of life (QOL) in adult hemodialysis (HD) patients.


METHODS
Patients were grouped based on the mean of five monthly phosphorus levels achieved during the study period. Group 1 included patients whose mean phosphorus levels over the period was <6.0 mg/dL (n = 24); group 2 averaged between 6.0 and 6.9 mg/dL (n = 14); and group 3 averaged >7.0 mg/dL (n = 16). Descriptive comparisons were made between phosphorus groups.


METHODS
Fifty-four stable, adult HD patients participated voluntarily.


METHODS
Intact-parathyroid hormone (iPTH), calcium x phosphorus product (Ca x P), and change in iPTH, albumin (alb), total protein (tpro), weight (wt) and body mass index (BMI), and scores on a QOL survey. Baseline physical and lab characteristics.


RESULTS
No difference was found between phosphorus levels of <6.0 mg/dL and levels of 6.0 to 6.9 mg/dL in iPTH, Ca x P levels allowing safe calcitriol therapy, nor response to calcitriol treatment. Patients with phosphorus levels >7.0 mg/dL had midstudy iPTH greater than phosphorus levels <6.0 mg/dL. Otherwise the three groups did not differ significantly in iPTH levels. Phosphorus levels 6.0 to 6.9 mg/dL was associated with lowest wt and BMI, but alb and tpro did not differ between the phosphorus groups. Phosphorus levels of >7.0 was associated with highest creatinine levels and youngest age. Subjects in the phosphorus levels of <6.0 mg/dL gp were more likely than the 6.0 to 6.9 mg/dL gp to describe their diet as sufficient and, at baseline, were more likely to relate diet to QOL.


CONCLUSIONS
Comparison of three levels of serum phosphorus on indicators of outcome in the control and treatment of secondary hyperparathyroidism showed no significant difference in outcome between phosphorus levels of <6.0 mg/dL and phosphorus levels 6.0 to 6.9 mg/dL. However, the data suggests that phosphorus levels of >7.0 mg/dL may relate to significantly higher iPTH and unacceptable Ca x P levels. There were no differences between the groups, suggesting less favorable outcome at any of the three phosphorus levels regarding nutritional status or QOL in this small group of stable, adult HD patients.
Greene
S V
SV
Renal Dietitian, Community Limited Care Dialysis Center, Cincinnati, OH, USA.
Falciglia
G
G
Rademacher
R
R
D000328:Adult; D002118:Calcium / Q000097:blood; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000097:blood / Q000209:etiology / Q000517:prevention & control*; D009752:Nutritional Status; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood*; D006435:Renal Dialysis / Q000009:adverse effects; D012709:Serum Albumin / Q000378:metabolism; D016896:Treatment Outcome
D010281:Parathyroid Hormone; D012709:Serum Albumin; D010758:Phosphorus; D002118:Calcium